Hermann Laferl

2.9k total citations
60 papers, 1.4k citations indexed

About

Hermann Laferl is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Hermann Laferl has authored 60 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 25 papers in Infectious Diseases and 21 papers in Hepatology. Recurrent topics in Hermann Laferl's work include Hepatitis C virus research (21 papers), Liver Disease Diagnosis and Treatment (15 papers) and Hepatitis B Virus Studies (12 papers). Hermann Laferl is often cited by papers focused on Hepatitis C virus research (21 papers), Liver Disease Diagnosis and Treatment (15 papers) and Hepatitis B Virus Studies (12 papers). Hermann Laferl collaborates with scholars based in Austria, Germany and Spain. Hermann Laferl's co-authors include Christoph Wenisch, Petra Steindl‐Munda, Péter Ferenci, Rudolf Stauber, A Maieron, Christian Datz, Michael Gschwantler, H. Brünner, Martin Bischof and Thomas–Matthias Scherzer and has published in prestigious journals such as The Lancet, Gastroenterology and Hepatology.

In The Last Decade

Hermann Laferl

59 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hermann Laferl Austria 19 829 688 608 119 114 60 1.4k
Jihad Slim United States 18 594 0.7× 428 0.6× 847 1.4× 94 0.8× 87 0.8× 131 1.5k
Ivana Maida Italy 24 950 1.1× 905 1.3× 727 1.2× 66 0.6× 105 0.9× 90 1.8k
Firouzé Bani‐Sadr France 20 742 0.9× 660 1.0× 502 0.8× 32 0.3× 63 0.6× 129 1.4k
Elina Kolho Finland 17 930 1.1× 508 0.7× 282 0.5× 41 0.3× 113 1.0× 38 1.4k
Marielle Buisson France 18 479 0.6× 299 0.4× 492 0.8× 44 0.4× 59 0.5× 39 1.1k
F. Raffi France 21 734 0.9× 197 0.3× 721 1.2× 83 0.7× 89 0.8× 71 1.5k
Caterina Uberti‐Foppa Italy 22 1.0k 1.2× 433 0.6× 632 1.0× 27 0.2× 70 0.6× 109 1.7k
Vitali Pool United States 16 489 0.6× 177 0.3× 529 0.9× 83 0.7× 76 0.7× 31 1.5k
Claudio Ucciferri Italy 20 342 0.4× 145 0.2× 376 0.6× 124 1.0× 216 1.9× 74 1.1k
Gabriella Verucchi Italy 21 1.5k 1.8× 1.5k 2.2× 286 0.5× 22 0.2× 102 0.9× 86 2.0k

Countries citing papers authored by Hermann Laferl

Since Specialization
Citations

This map shows the geographic impact of Hermann Laferl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hermann Laferl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hermann Laferl more than expected).

Fields of papers citing papers by Hermann Laferl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hermann Laferl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hermann Laferl. The network helps show where Hermann Laferl may publish in the future.

Co-authorship network of co-authors of Hermann Laferl

This figure shows the co-authorship network connecting the top 25 collaborators of Hermann Laferl. A scholar is included among the top collaborators of Hermann Laferl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hermann Laferl. Hermann Laferl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aberle, Stephan W., Marianna Traugott, Hermann Laferl, et al.. (2022). Monkeypox associated acute arthritis. The Lancet Rheumatology. 4(11). e804–e804. 9 indexed citations
2.
Pawelka, Erich, Mario Karolyi, Sarah Ely, et al.. (2021). COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria. Infection. 49(5). 907–916. 12 indexed citations
3.
Karolyi, Mario, Erich Pawelka, Bernd Jilma, et al.. (2021). High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19. Frontiers in Pharmacology. 12. 704767–704767. 7 indexed citations
4.
Traugott, Marianna, Wolfgang Hoepler, Tamara Seitz, et al.. (2020). Diagnosis of COVID-19 using multiple antibody assays in two cases with negative PCR results from nasopharyngeal swabs. Infection. 49(1). 171–175. 7 indexed citations
5.
Seitz, Tamara, Wolfgang Hoepler, Lukas Weseslindtner, et al.. (2020). Successful management of the first reported case in Austria of COVID-19 with ARDS. Infection. 48(4). 647–651. 11 indexed citations
6.
Karolyi, Mario, Erich Pawelka, Hermann Laferl, et al.. (2020). Late onset pulmonary embolism in young male otherwise healthy COVID-19 patients. European Journal of Clinical Microbiology & Infectious Diseases. 40(3). 633–635. 8 indexed citations
7.
Laferl, Hermann, Tamara Seitz, Barbara Holzer, et al.. (2020). An approach to lifting self-isolation for health care workers with prolonged shedding of SARS-CoV-2 RNA. Infection. 49(1). 95–101. 22 indexed citations
8.
Karolyi, Mario, et al.. (2019). Is there a clinical difference between influenza A and B virus infections in hospitalized patients?. Wiener klinische Wochenschrift. 131(15-16). 362–368. 5 indexed citations
9.
Schmid, Daniela, Gerhard Tucek, Hung-Wei Kuo, et al.. (2012). A prospective cohort study on hospital mortality due to Clostridium difficile infection. Infection. 40(5). 479–484. 34 indexed citations
10.
Maieron, A, Sigrid Metz-Gercek, Thomas–Matthias Scherzer, et al.. (2011). Shortening of treatment duration in patients with chronic hepatitis C genotype 2 and 3 - impact of ribavirin dose - a randomized multicentre trial. BMC Research Notes. 4(1). 220–220. 1 indexed citations
11.
Ferenci, Peter, Hermann Laferl, Thomas–Matthias Scherzer, et al.. (2009). Peginterferon Alfa-2a/Ribavirin for 48 or 72 Weeks in Hepatitis C Genotypes 1 and 4 Patients With Slow Virologic Response. Gastroenterology. 138(2). 503–512.e1. 86 indexed citations
12.
Ferenci, Péter, Hermann Laferl, Thomas–Matthias Scherzer, et al.. (2008). Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response. Gastroenterology. 135(2). 451–458. 201 indexed citations
13.
Ferenci, Péter, H. Brünner, Hermann Laferl, et al.. (2008). A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3. Hepatology. 47(6). 1816–1823. 49 indexed citations
14.
Aberle, Judith H., Elisabeth Formann, Petra Steindl‐Munda, et al.. (2006). Prospective study of viral clearance and CD4+ T-cell response in acute hepatitis C primary infection and reinfection. Journal of Clinical Virology. 36(1). 24–31. 56 indexed citations
15.
Laferl, Hermann, et al.. (2005). Imported dengue fever in Austria 1990–2005. Travel Medicine and Infectious Disease. 4(6). 319–323. 15 indexed citations
16.
Koehler, Gerd, et al.. (2005). Rapid Reversible Coma with Intravenous Gamma-Hydroxybutyrate in a Moxifloxacin-Treated Patient. Clinical Drug Investigation. 25(8). 551–554.
17.
Wichmann, Ole, Tomáš Jelı́nek, Gabriele Peyerl‐Hoffmann, et al.. (2003). Molecular surveillance of the antifolate-resistant mutation I164L in imported african isolates of Plasmodium falciparum in Europe: sentinel data from TropNetEurop. Malaria Journal. 2(1). 17–17. 12 indexed citations
18.
Laferl, Hermann, et al.. (2003). How Safe is Safe? – A Case of Lactobacillus paracasei ssp. paracasei Endocarditis and Discussion of the Safety of Lactic Acid Bacteria. Scandinavian Journal of Infectious Diseases. 35(10). 759–762. 30 indexed citations
19.
Laferl, Hermann. (1997). Pleural effusion and ascites on return from Pakistan. The Lancet. 350(9084). 1072–1072. 4 indexed citations
20.
Graninger, W., Konstantin Zedtwitz‐Liebenstein, Hermann Laferl, & Heinz Burgmann. (1996). Quinolones in Gastrointestinal Infections. Chemotherapy. 42(1). 43–53. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jihad Slim Breakdown of academic impact, for papers by Ivana Maida Breakdown of academic impact, for papers by Firouzé Bani‐Sadr Breakdown of academic impact, for papers by Elina Kolho Breakdown of academic impact, for papers by Marielle Buisson Breakdown of academic impact, for papers by F. Raffi Breakdown of academic impact, for papers by Caterina Uberti‐Foppa Breakdown of academic impact, for papers by Vitali Pool Breakdown of academic impact, for papers by Claudio Ucciferri Breakdown of academic impact, for papers by Gabriella Verucchi
Rankless by CCL
2026